Related Experiment Video
Updated: Dec 30, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Advances in HDL: Much More than Lipid Transporters
Soumaya Ben-Aicha1,2, Lina Badimon1,3,4, Gemma Vilahur1,3
1Cardiovascular ICCC Program, Research Institute-Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08001 Barcelona, Spain.
Insights
High Density Lipoprotein (HDL) particles offer cardiovascular protection but can be altered by risk factors. HDL functionality and composition, not just cholesterol levels, may better indicate heart health and guide therapeutic approaches.
Area of Science:
- Cardiovascular Biology
- Lipid Metabolism
- Biochemistry
Background:
- High Density Lipoprotein (HDL) particles are crucial for reverse cholesterol transport and cardiovascular health.
- HDL particles transport diverse molecules, including proteins, micro-RNAs, vitamins, and hormones, mediating various cellular functions.
- Cardiovascular risk factors and co-morbidities can negatively impact HDL composition and its protective functions.
Purpose of the Study:
- To provide an overview of molecules transported by HDL and their cardiovascular functions.
- To describe the remodeling of HDL under cardiovascular risk factors and co-morbidities.
- To review current HDL-based therapeutic and drug-delivery approaches.
Main Methods:
- Literature review of HDL composition and function.
- Analysis of the impact of cardiovascular risk factors on HDL.
- Survey of engineered HDL-mimetics and HDL-based therapies.
Main Results:
- HDL carries a multitude of molecules that promote cardiovascular health.
- HDL's cargo and protective capacity are significantly altered by cardiovascular risk factors.
- HDL functionality and composition are emerging as more relevant metrics than HDL-cholesterol levels for assessing cardiovascular protection.
Conclusions:
- HDL's role in cardiovascular health is complex and influenced by its cargo and remodeling.
- Assessing HDL functionality and composition is critical for understanding its protective effects.
- HDL-based strategies, including engineered mimetics, hold therapeutic promise for cardiovascular diseases.
Abstract:
High Density Lipoprotein (HDL) particles, beyond serving as lipid transporters and playing a key role in reverse cholesterol transport, carry a highly variable number of proteins, micro-RNAs, vitamins, and hormones, which endow them with the ability to mediate a plethora of cellular and molecular mechanisms that promote cardiovascular health. It is becoming increasingly evident, however, that the presence of cardiovascular risk factors and co-morbidities alters HDLs cargo and protective functions. This concept has led to the notion that metrics other than HDL-cholesterol levels, such as HDL functionality and composition, may better capture HDL cardiovascular protection. On the other hand, the potential of HDL as natural delivery carriers has also fostered the design of engineered HDL-mimetics aiming to improve HDL efficacy or as drug-delivery agents with therapeutic potential. In this paper, we first provide an overview of the molecules known to be transported by HDL particles and mainly discuss their functions in the cardiovascular system. Second, we describe the impact of cardiovascular risk factors and co-morbidities on HDL remodeling. Finally, we review the currently developed HDL-based approaches.
Related Concept Videos
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Atherosclerosis III: Management
Receptor-mediated Endocytosis

